HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 7 analysts with an average price target of $53.68. This is a potential upside of $13.85 (34.77%) from yesterday's end of day stock price of $39.83.

Harmony Biosciences Holdings's activity chart (see below) currently has 115 price targets and 106 ratings on display. The stock rating distribution of HRMY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.19% with an average time for these price targets to be met of 81.58 days.

Highest price target for HRMY is $70, Lowest price target is $36, average price target is $48.43.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 24-Nov-2025. First documented stock forecast 11-Sep-2020.

Split History since 2000:

12/5/00 3 for 1

Currently out of the existing stock ratings of HRMY, 26 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$42

$6.71 (19.01%)

$41

13 days ago
(24-Nov-2025)

3/28 (10.71%)

$6.73 (19.08%)

332

Buy

$39

$3.71 (10.51%)

$35

1 months 1 days ago
(06-Nov-2025)

10/25 (40%)

$8.06 (26.05%)

112

Buy

$43

$7.71 (21.85%)

$55

1 months 22 days ago
(15-Oct-2025)

0/3 (0%)

$16.37 (61.47%)

Buy

$36

$0.71 (2.01%)

$55

2 months 12 days ago
(25-Sep-2025)

0/4 (0%)

$8.96 (33.14%)

Buy

$48

$12.71 (36.02%)

$40

4 months 16 days ago
(21-Jul-2025)

6/9 (66.67%)

$12.75 (36.17%)

116

Show more analysts

Please expand the browser size to see the chart

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 81.58 days on average for the stock forecasts to be realized with a an average price target met ratio 33.19

Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

AMI FADIA

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia works at NEEDHAM and has 7 price targets and 4 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Patrick Trucchio with highest potential upside - $34.71

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Corinne Jenkins with lowest potential downside - -$7.29

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?